Fig. 4

Kaplan–Meier survival curves depicting the association between dichotomized cMyBP-C levels and 1-year MACEs in patients with stable CAD. The curve illustrates the significantly increased risk of 1-year MACEs in patients with cMyBP-C concentrations above the median (cMyBP-C ≥ 27 pg/ml) compared to the low cMyBP-C concentration group (cMyBP-C < 27 pg/ml) (Log-rank P = 0.0014). CAD, coronary artery disease; cMyBP-C, cardiac myosin-binding protein-C; MACEs, major adverse cardiovascular events.